Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 142.00 | |
5 mg | In stock | $ 347.00 | |
10 mg | In stock | $ 519.00 | |
25 mg | In stock | $ 842.00 | |
50 mg | In stock | $ 1,160.00 | |
100 mg | In stock | $ 1,570.00 | |
500 mg | In stock | $ 3,130.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 298.00 |
Description | FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays. |
Targets&IC50 | Autophagin-1 (FRET assay):80 nM, Autophagin-1 (LRA assay):73 nM |
In vitro | FMK 9a forms a covalent bond with the more reactive thiol group of Cys74 located at the catalytic site of ATG4B thereby inactivating ATG4B proteolytic activity[1]. |
In vivo | FMK 9a shows moderate solubility and high liver microsome clearances for human and mice of 13.9 and 70 mL/kg/min[1]. |
Molecular Weight | 392.42 |
Formula | C23H21FN2O3 |
CAS No. | 1955550-51-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (242.09 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FMK 9a 1955550-51-2 Autophagy Proteases/Proteasome Cysteine Protease inhibit Inhibitor inhibitor